Cara Therapeutic Stock Price on May 2, 2024
| CARA Stock | USD 0.75 0.06 7.41% |
Below is the normalized historical share price chart for Cara Therapeutic extending back to January 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cara Therapeutic stands at 0.75, as last reported on the 20th of May, with the highest price reaching 0.80 and the lowest price hitting 0.75 during the day.
If you're considering investing in Cara Stock, it is important to understand the factors that can impact its price. Cara Therapeutic appears to be very risky, given 3 months investment horizon. Cara Therapeutic secures Sharpe Ratio (or Efficiency) of 0.0688, which signifies that the company had a 0.0688% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Cara Therapeutic, which you can use to evaluate the volatility of the firm. Please makes use of Cara Therapeutic's Downside Deviation of 6.15, mean deviation of 5.5, and Risk Adjusted Performance of 0.0635 to double-check if our risk estimates are consistent with your expectations.
At present, Cara Therapeutic's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 136.4 M, whereas Common Stock Total Equity is forecasted to decline to about 33.2 K. . As of May 20, 2024, Price To Sales Ratio is expected to decline to 1.82. In addition to that, Price Earnings Ratio is expected to decline to -0.36. Cara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of January 2014 | 200 Day MA 1.2153 | 50 Day MA 0.8005 | Beta 0.734 |
Cara |
Sharpe Ratio = 0.0688
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CARA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.13 actual daily | 63 63% of assets are less volatile |
Expected Return
| 0.49 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Cara Therapeutic is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cara Therapeutic by adding it to a well-diversified portfolio.
Price Book 0.7316 | Enterprise Value Ebitda 0.4497 | Price Sales 1.9917 | Shares Float 46.8 M | Wall Street Target Price 5.23 |
Cara Therapeutic Main Headline on 2nd of May 2024
Disposition of 36 shares by Christopher Posner of Cara Thera... by MacroaxisInsider
Filed transaction by Cara Therapeutic Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Cara Therapeutic Valuation on May 2, 2024
It is possible to determine the worth of Cara Therapeutic on a given historical date. On May 2, 2024 Cara was worth 0.75 at the beginning of the trading date compared to the closed value of 0.77. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cara Therapeutic stock. Still, in general, we apply an absolute valuation method to find Cara Therapeutic's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cara Therapeutic where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cara Therapeutic's related companies.
| Open | High | Low | Close | Volume | |
| 0.76 | 0.78 | 0.72 | 0.76 | 190,425 | |
05/02/2024 | 0.75 | 0.79 | 0.74 | 0.77 | 192,965 |
| 0.80 | 0.80 | 0.76 | 0.78 | 159,125 |
| Backtest Cara Therapeutic | | | Cara Therapeutic History | | | Cara Therapeutic Valuation | Previous | Next |
Cara Therapeutic Trading Date Momentum on May 2, 2024
| On May 03 2024 Cara Therapeutic was traded for 0.78 at the closing time. The top price for the day was 0.80 and the lowest listed price was 0.76 . The trading volume for the day was 159.1 K. The trading history from May 3, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 1.30% . The overall trading delta against the current closing price is 2.60% . |
Cara Therapeutic Fundamentals Correlations and Trends
By evaluating Cara Therapeutic's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cara Therapeutic's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cara financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cara Therapeutic Stock history
Cara Therapeutic investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cara Therapeutic will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cara Therapeutic stock prices may prove useful in developing a viable investing in Cara Therapeutic
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 54.1 M | 35.8 M | |
| Net Loss | -76.9 M | -80.8 M |
Cara Therapeutic Quarterly Net Working Capital |
|
Cara Therapeutic Stock Technical Analysis
Cara Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cara Therapeutic Period Price Range
Low | May 2, 2024
| High |
0.75 | 0.77 |
Cara Therapeutic May 20, 2024 Market Strength
Market strength indicators help investors to evaluate how Cara Therapeutic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cara Therapeutic shares will generate the highest return on investment. By undertsting and applying Cara Therapeutic stock market strength indicators, traders can identify Cara Therapeutic entry and exit signals to maximize returns
| Accumulation Distribution | 12212.97 | |||
| Daily Balance Of Power | 0.4 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 0.77 | |||
| Day Typical Price | 0.77 | |||
| Price Action Indicator | 0.015 | |||
| Period Momentum Indicator | (0.02) |
Cara Therapeutic Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cara Therapeutic's price direction in advance. Along with the technical and fundamental analysis of Cara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0635 | |||
| Jensen Alpha | 0.1608 | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.0903 | |||
| Treynor Ratio | 0.1191 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cara Therapeutic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Cara Stock analysis
When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Cara Therapeutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.26) | Revenue Per Share 0.312 | Quarterly Revenue Growth (0.65) | Return On Assets (0.62) | Return On Equity (1.47) |
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.